Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
1.800
+0.010 (0.56%)
At close: Oct 31, 2025, 4:00 PM EDT
1.820
+0.020 (1.11%)
After-hours: Oct 31, 2025, 7:57 PM EDT
Bionano Genomics Market Cap
Bionano Genomics has a market cap or net worth of $17.42 million as of October 31, 2025. Its market cap has decreased by -38.56% in one year.
Market Cap
17.42M
Enterprise Value
20.57M
1-Year Change
-38.56%
Ranking
Category
Stock Price
$1.80
Market Cap Chart
Since September 21, 2018, Bionano Genomics's market cap has decreased from $66.34M to $17.42M, a decrease of -73.74%. That is a compound annual growth rate of -17.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 17.33M | -41.09% |
| Dec 31, 2024 | 29.41M | -59.93% |
| Dec 29, 2023 | 73.41M | -83.07% |
| Dec 30, 2022 | 433.51M | -49.86% |
| Dec 31, 2021 | 864.66M | 83.26% |
| Dec 31, 2020 | 471.81M | 1,336.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 756.15B |
| Johnson & Johnson | 455.48B |
| AbbVie | 403.13B |
| UnitedHealth Group | 312.23B |
| AstraZeneca | 255.76B |
| Novartis AG | 236.67B |
| Novo Nordisk | 222.08B |
| Abbott Laboratories | 216.98B |